adplus-dvertising
Connect with us

Health

U.S. to accept travellers immunized with Astra-Zeneca, other non-FDA approved COVID-19 vaccines – CP24 Toronto's Breaking News

Published

 on


Sarah Smellie and Laura Osman, The Canadian Press


Published Monday, October 11, 2021 2:04PM EDT


Last Updated Monday, October 11, 2021 8:18PM EDT

Canadians immunized against COVID-19 with the Oxford-AstraZeneca vaccine can visit the United States when new travel regulations come into play next month, but it’s not yet clear whether those with mixed doses will make the cut.

The U.S. Centers for Disease Control and Prevention said Monday travellers will be able to fly to the States if they’ve received shots of vaccines approved or recognized for emergency use by the World Health Organization or the U.S. Food and Drug Administration.

It did not say whether that included people who had received a mixed-dose regimen of approved vaccines.

“CDC will release additional guidance and information as the travel requirements are finalized,” said a statement from spokeswoman Jasmine Reed on Monday.

The agency began informing airlines of its decision last week, she added.

Evan Rachkovsky, a spokesman with theCanadian Snowbird Association, welcomed the decision but said members had concerns and questions about those who received two different doses of vaccines.

“You’re talking about millions of Canadians who aren’t going to be permitted entry into the U.S., based on the fact that they have two different vaccine doses,” Rachkovsky said.

“We do remain hopeful that not only people with AstraZeneca, but travellers with the mixed doses as well, will be permitted entry into the U.S.”

Last month, White House officials said international travellers would be allowed to visit beginning in November as long as they were fully vaccinated. They did not say which vaccines would meet that criteria.

The U.S. Food and Drug Administration has approved three COVID-19 vaccines, and AstraZeneca was not among them. It is, however, approved by the WHO. It also does not allow for mixing doses of Pfizer and Moderna.

More than 3.9 million Canadians have two different doses of Health Canada approved COVID-19 vaccines, not including Quebec, which does not categorize data by vaccine product.

Of those, approximately 1.6 million had a dose of the AstraZeneca formula followed by an mRNA vaccine, data from the Public Health Agency of Canada shows. It’s not yet clear whether those who have received a mixed-dose regimen will meet the criteria.

The COVID-19 vaccines approved under the WHO’s emergency use listing have only been assessed as single product regimens, meaning people receive the same vaccine for both shots.

But the agency’s Strategic Advisory Group of Experts on Immunization recommends mRNA vaccines – Pfizer-BioNTech or Moderna – can be used as a second dose following a first one with AstraZeneca if a second shot of the same is not available.

The U.S. Centers for Disease Control and Prevention did not respond to a request for comment.

Canada is one of only a few countries that opted to mix vaccine types for their first and second doses last summer.

Canadian public health officials have shared data with U.S. counterparts and governments of high-priority destinations about the efficacy of mixing doses in an effort to inform their travel and border policies during the pandemic.

Mike McNaney, spokesman for the National Airlines Council of Canada, said the group welcomes the U.S. Centers for Disease Control and Prevention’s decision.

“As countries move forward and recognize WHO approved vaccines, it underscores the critical need for the Canadian government to do likewise, and accept the global standard established by the WHO,” he said in a statement.

Ottawa recognizes the Moderna and Pfizer-BioNTech mRNA vaccines, as well as the AstraZeneca and Johnson & Johnson vaccines, but not the WHO-approved Sinopharm or Sinovac shots. The U.S. Centers for Disease Control and Prevention decision means American officials will recognize all six.

Travellers to Canada can only be considered fully vaccinated if they have two doses of Health Canada-approved vaccines at least 14 days before entering the country.

Health Canada said in a statement that the list of accepted vaccines may expand in the future as research grows.

Genevieve Tremblay, a spokeswoman for Global Affairs Canada, said Ottawa “respects the right of the United States to determine its border restrictions.”

The Canadian government is working with the U.S. to recognize different vaccine strategies including mixed doses and extended intervals between shots, she said in a statement Saturday.

The new travel rules in the United States replace Trump-era travel bans that restricted visits to the U.S. by those who had recently been in the United Kingdom, the European Union, China, India, Iran, Ireland, Brazil and South Africa.

Passengers will have to show proof of vaccination before boarding, as well as a negative COVID-19 test taken no more than three days before departure.

Meanwhile the land border between the U.S. and Canada is set to remain closed until at least Oct. 21.

– With files from James McCarten

This report by The Canadian Press was first published Oct. 11, 2021.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending